Bellevue Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-165
| Closed | -$2K | – | 550 |
|
|
2021
Q4 | $2K | Sell |
165
-14
| -8% | -$170 | ﹤0.01% | 495 |
|
|
2021
Q3 | $2K | Hold |
179
| – | – | ﹤0.01% | 519 |
|
|
2021
Q2 | $3K | Sell |
179
-21
| -11% | -$352 | ﹤0.01% | 453 |
|
|
2021
Q1 | $3K | Sell |
200
-21
| -10% | -$315 | ﹤0.01% | 512 |
|
|
2020
Q4 | $4K | Sell |
221
-51
| -19% | -$923 | ﹤0.01% | 464 |
|
|
2020
Q3 | $4K | Hold |
272
| – | – | ﹤0.01% | 426 |
|
|
2020
Q2 | $4K | Hold |
272
| – | – | ﹤0.01% | 425 |
|
|
2020
Q1 | $4K | Buy |
+272
| New | +$4K | ﹤0.01% | 414 |
|